News Roundup: June 19 to June 23

Article

Sandoz Launches Action Plan to Increase Global Biosimilar Access


The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.


Read More

Insurance Coverage is Lagging in a Golden Age of Obesity Treatment


Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.


Read More

First Gene Therapy to Treat Pediatric Duchenne Muscular Dystrophy Approved by FDA


The accelerated approval of delandistrogene moxeparvovec-rokl is “based on expression of Elevidys micro-dystrophin observed in patients treated with ELEVIDYS,” according to Sarepta Therapeutics.


Read More

What’s New in Next-Generation Vaccines for Respiratory Viruses?


A recent review evaluated possible approaches for new vaccines targeting respiratory viruses.


Read More

The Effectiveness of Biologics in Preventing Penetrating Complications in Patients With CD


A study presented at Digestive Disease Week 2023 compared the effectiveness of different approaches to prevent complications in individuals with the common disease.


Read More

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.